184 related articles for article (PubMed ID: 31540260)
1. In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome.
Piñeiro-Yáñez E; Jiménez-Santos MJ; Gómez-López G; Al-Shahrour F
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540260
[TBL] [Abstract][Full Text] [Related]
2. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
[TBL] [Abstract][Full Text] [Related]
3. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract][Full Text] [Related]
4. PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data.
Jiménez-Santos MJ; Nogueira-Rodríguez A; Piñeiro-Yáñez E; López-Fernández H; García-Martín S; Gómez-Plana P; Reboiro-Jato M; Gómez-López G; Glez-Peña D; Al-Shahrour F
Nucleic Acids Res; 2023 Jul; 51(W1):W411-W418. PubMed ID: 37207338
[TBL] [Abstract][Full Text] [Related]
5. A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma.
Luo S; Jia Y; Zhang Y; Zhang X
JHEP Rep; 2023 Jun; 5(6):100754. PubMed ID: 37234275
[TBL] [Abstract][Full Text] [Related]
6. Quantification of within-sample genetic heterogeneity from SNP-array data.
Martinez P; Kimberley C; BirkBak NJ; Marquard A; Szallasi Z; Graham TA
Sci Rep; 2017 Jun; 7(1):3248. PubMed ID: 28607403
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information.
Wang Y; Ali MA; Vallon-Christersson J; Humphreys K; Hartman J; Rantalainen M
Eur J Cancer; 2023 Sep; 191():112953. PubMed ID: 37494846
[TBL] [Abstract][Full Text] [Related]
9. Overview on Clinical Relevance of Intra-Tumor Heterogeneity.
Stanta G; Bonin S
Front Med (Lausanne); 2018; 5():85. PubMed ID: 29682505
[TBL] [Abstract][Full Text] [Related]
10. Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer.
Yang C; Zhang S; Cheng Z; Liu Z; Zhang L; Jiang K; Geng H; Qian R; Wang J; Huang X; Chen M; Li Z; Qin W; Xia Q; Kang X; Wang C; Hang H
Genome Med; 2022 Dec; 14(1):142. PubMed ID: 36527145
[TBL] [Abstract][Full Text] [Related]
11. Intratumour heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification: a descriptive study.
Cuevas D; Velasco A; Vaquero M; Santacana M; Gatius S; Eritja N; Estaran E; Matias-Guiu X
Histopathology; 2020 Feb; 76(3):447-460. PubMed ID: 31550396
[TBL] [Abstract][Full Text] [Related]
12. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities.
Rubio-Perez C; Tamborero D; Schroeder MP; Antolín AA; Deu-Pons J; Perez-Llamas C; Mestres J; Gonzalez-Perez A; Lopez-Bigas N
Cancer Cell; 2015 Mar; 27(3):382-96. PubMed ID: 25759023
[TBL] [Abstract][Full Text] [Related]
13. Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours.
Khalique L; Ayhan A; Weale ME; Jacobs IJ; Ramus SJ; Gayther SA
J Pathol; 2007 Feb; 211(3):286-95. PubMed ID: 17154249
[TBL] [Abstract][Full Text] [Related]
14. Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma.
Affinito O; Orlandella FM; Luciano N; Salvatore M; Salvatore G; Franzese M
Cancer Cell Int; 2022 Aug; 22(1):263. PubMed ID: 35996174
[TBL] [Abstract][Full Text] [Related]
15. In silico drug combination discovery for personalized cancer therapy.
Jeon M; Kim S; Park S; Lee H; Kang J
BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
[TBL] [Abstract][Full Text] [Related]
16. Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling.
Ai H; Song D; Wang X
Comput Biol Med; 2023 Jun; 159():106964. PubMed ID: 37099972
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality-dependent prognostic patterns.
Luo S; Zhang Y; Jia Y; Zhang X
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12831. PubMed ID: 35767937
[TBL] [Abstract][Full Text] [Related]
18. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
19. Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer.
Tan TZ; Heong V; Ye J; Lim D; Low J; Choolani M; Scott C; Tan DSP; Huang RY
J Pathol; 2019 Mar; 247(3):305-319. PubMed ID: 30374975
[TBL] [Abstract][Full Text] [Related]
20. Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective.
Perales-Patón J; Piñeiro-Yañez E; Tejero H; López-Casas PP; Hidalgo M; Gómez-López G; Al-Shahrour F
Public Health Genomics; 2017; 20(2):81-91. PubMed ID: 28858862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
